title: Letter to the Editor - responses to Weisntein D, Simon M, Yehezkel E, Laron Z, Werner H. Insulin analogues display IGF-I-like mitogenic and antiactivity in cultured cancer cells.
abstract: We thank the team of Eli Lilly and Company for their critical appraisal of our study and for giving us the opportunity to clarify a number of points [1]. We agree with Kazda et al. that randomized clinical trials will best address any direct relationship between insulin analogues and cancer in man. We do not question the fact that tight control of blood glucose has dramatically advanced the lives of patients with diabetes. This article is protected by copyright. All rights reserved.
authors: Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, 69978; Endocrine and Diabetes Research Unit, Schneider Children's Medical Center, Petah Tikva, 49292, Israel.
authors: Doron
authors: D
authors: Weinstein
authors: Meital
authors: M
authors: Simon
authors: Einat
authors: E
authors: Yehezkel
authors: Zvi
authors: Z
authors: Laron
authors: Haim
authors: H
authors: Werner
keywords: blood glucose; cancer; insulin analogues